Harvard Bioscience shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Harvard Bioscience (HBIO) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Harvard Bioscience
Tip: Access up to 7 years of quarterly data
All positions including Harvard Bioscience held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Harvard Bioscience by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $757k | 142k | 5.35 |
| 2023-09-30 | $696k | 162k | 4.30 |
| 2023-06-30 | $542k | 99k | 5.49 |
| 2021-12-31 | $382k | 54k | 7.04 |
| 2021-09-30 | $484k | 69k | 6.98 |
| 2021-06-30 | $513k | 62k | 8.33 |
| 2021-03-31 | $342k | 63k | 5.45 |
| 2020-12-31 | $343k | 80k | 4.28 |
| 2020-09-30 | $296k | 98k | 3.01 |
| 2020-06-30 | $151k | 49k | 3.09 |
| 2020-03-31 | $101k | 46k | 2.21 |
| 2019-12-31 | $126k | 41k | 3.06 |
| 2019-09-30 | $128k | 42k | 3.07 |
| 2014-12-31 | $84k | 13k | 6.56 |
| 2014-09-30 | $49k | 12k | 4.05 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management